SELLAS Life Sciences Group Inc. (SLS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    SELLAS Life Sciences Grou...

    NASDAQ: SLS · Real-Time Price · USD
    1.87
    0.16 (9.36%)
    At close: Oct 03, 2025, 3:59 PM
    1.88
    0.53%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    SELLAS Life Sciences Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -20.61 -7.1 -1.11 -4.14
    PEG Ratio
    		 0.31 0.08 -0.02 0.11
    PS Ratio
    		 n/a n/a 45.77 11.26
    PB Ratio
    		 67.25 -33.22 9.44 4.21
    P/FCF Ratio
    		 -17.98 -7.18 -1.62 -3.29
    P/OCF Ratio
    		 -17.98 -8.44 -1.92 -3.29
    OCF/S Ratio
    		 n/a n/a -23.81 -3.42
    Debt / Equity Ratio
    		 0.11 -0.11 0.19 0.04
    Quick Ratio
    		 1.72 0.23 1.14 4.63
    Current Ratio
    		 1.72 0.23 1.14 4.63
    Asset Turnover
    		 n/a n/a 0.05 0.29
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -3.26 4.68 -8.51 -1.02
    Return on Assets
    		 -1.59 -6 -1.97 -0.79
    Return on Invested Capital
    		 -2.86 5.72 -6.8 -1.15
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a 0.90 0.97
    Net Profit Margin
    		 n/a n/a -41.3 -2.72
    Pretax Profit Margin
    		 n/a n/a -41.3 -2.75
    Operating Profit Margin
    		 n/a n/a -41.95 -3.33
    FCF Margin
    		 n/a n/a -28.31 -3.42
    EBITDA Margin
    		 n/a n/a -31.95 -2.58

    Add to Watchlist